On August 31, 2026, Chaoju Eye Care (02219) announced that it had repurchased 873,500 shares at a total cost of approximately HK$2.0774 million, with the buyback price ranging from HK$2.355 to HK$2.47 per share.
This share repurchase activity reflects the company's ongoing capital management strategy, as it continues to utilize its cash reserves to reduce the outstanding share count and potentially enhance shareholder value.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.